Our experiments utilizing different MM cell lines consistently showed that knockout of PRMT1 significantly delayed MM tumor progression in vivo and extended the survival of tumor-bearing mice (Figures 6B, C, Supplementary Figure 6). This evidence concerns the gene PRMT1 and Miyoshi myopathy.